Satoshi O Suzuki Selected Research

autosomal recessive Spastic paraplegia 11

8/2021

Transactivation response DNA-binding protein of 43 kDa proteinopathy and lysosomal abnormalities in spastic paraplegia type 11.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoshi O Suzuki Research Topics

Disease

34	Neoplasms (Cancer) 06/2022 - 05/2002
19	Glioma (Gliomas) 07/2021 - 05/2002
16	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 09/2007
7	Astrocytoma (Pilocytic Astrocytoma) 07/2021 - 09/2007
6	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 08/2021 - 04/2002
6	Brain Neoplasms (Brain Tumor) 01/2018 - 07/2007
5	Cysts 01/2022 - 12/2006
5	Demyelinating Diseases (Demyelinating Disease) 11/2020 - 11/2010
4	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2021 - 04/2012
4	Epilepsy (Aura) 01/2021 - 08/2003
3	Dermoid Cyst (Dermoid) 01/2022 - 06/2016
3	Oligodendroglioma 07/2021 - 02/2011
3	Neuromyelitis Optica (Devic's Disease) 01/2017 - 09/2011
3	Meningioma (Meningiomas) 04/2012 - 07/2007
2	Disease Progression 06/2022 - 03/2014
2	Abscess 01/2022 - 06/2016
2	Ganglioglioma 01/2021 - 06/2017
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2021 - 02/2011
2	Necrosis 10/2019 - 03/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2019 - 12/2018
2	Sarcoma (Soft Tissue Sarcoma) 10/2019 - 02/2011
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 06/2014
2	Atrophy 10/2017 - 11/2009
2	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 06/2017 - 09/2007
2	Subacute Sclerosing Panencephalitis (SSPE) 03/2015 - 03/2013
2	Infections 02/2015 - 01/2013
2	Carcinoma (Carcinomatosis) 06/2013 - 12/2012
2	Neurilemmoma (Schwannoma) 04/2012 - 07/2007
2	Temporal Lobe Epilepsy 09/2010 - 08/2003
2	Hydrocephalus (Hydrocephaly) 09/2007 - 12/2006
1	Leukocytosis (Pleocytosis) 10/2022
1	Tuberculosis (Tuberculoses) 10/2022
1	Suppuration 01/2022
1	autosomal recessive Spastic paraplegia 11 08/2021
1	Ganglion Cysts (Ganglion) 08/2021
1	Proteostasis Deficiencies 08/2021
1	Spinal Dysraphism (Spina Bifida) 01/2021
1	Cerebellar Neoplasms 01/2021
1	Frontotemporal Dementia (Semantic Dementia) 01/2021
1	Central Nervous System Neoplasms 12/2020

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 10/2022 - 08/2003
5	Glial Fibrillary Acidic ProteinIBA 01/2022 - 11/2010
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 07/2021 - 12/2013
5	Messenger RNA (mRNA)IBA 10/2019 - 07/2007
3	DNA-Binding Proteins (DNA Binding Protein)IBA 08/2021 - 02/2011
3	Carrier Proteins (Binding Protein)IBA 01/2021 - 01/2018
3	Prion ProteinsIBA 01/2021 - 11/2016
3	GadoliniumIBA 12/2019 - 01/2013
3	Dyneins (Dynein)IBA 12/2018 - 05/2007
3	Cytoplasmic DyneinsIBA 12/2018 - 05/2007
3	DNA (Deoxyribonucleic Acid)IBA 06/2017 - 04/2008
3	Capsules (Microcapsules)IBA 06/2016 - 04/2009
3	Connexin 43 (Connexin43)IBA 03/2014 - 06/2012
3	Immunoglobulins (Immunoglobulin)IBA 01/2013 - 11/2010
3	Complement System Proteins (Complement)IBA 01/2013 - 11/2010
2	Keratins (Keratin)IBA 01/2022 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2021
2	Histones (Histone)IBA 12/2020 - 07/2017
2	Temozolomide (Temodar)FDA LinkGeneric 02/2020 - 12/2013
2	Bevacizumab (Avastin)FDA Link 02/2020 - 01/2017
2	Dynactin ComplexIBA 12/2018 - 05/2007
2	MicroRNAs (MicroRNA)IBA 01/2018 - 08/2010
2	Peptide Hydrolases (Proteases)FDA Link 10/2017 - 04/2012
2	Codon (Codons)IBA 07/2017 - 11/2016
2	Valine (L-Valine)FDA Link 07/2017 - 07/2014
2	Biological ProductsIBA 07/2017 - 06/2017
2	2,6-dinitrotoluene (DNT)IBA 06/2017 - 01/2011
2	AmidesIBA 02/2017 - 03/2014
2	Protons (Proton)IBA 02/2017 - 03/2014
2	APTIBA 02/2017 - 03/2014
2	Amyloid (Amyloid Fibrils)IBA 01/2017 - 06/2014
2	Vincristine (Oncovin)FDA LinkGeneric 01/2016 - 09/2007
2	Protein Isoforms (Isoforms)IBA 10/2014 - 05/2002
2	Glutamic Acid (Glutamate)FDA Link 07/2014 - 08/2003
2	Excitatory Amino AcidsIBA 03/2014 - 08/2003
2	ConnexinsIBA 03/2014 - 06/2012
2	Therapeutic UsesIBA 04/2012 - 07/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2011 - 07/2007
2	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 02/2011 - 07/2010
2	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2008 - 07/2005
2	LigandsIBA 01/2008 - 07/2005
1	GoldIBA 10/2022
1	imidazoleacetic acid (IMAC)IBA 01/2022
1	MucinsIBA 10/2021
1	Lysosomal Membrane ProteinsIBA 08/2021
1	alectinibIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 01/2021
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2021
1	ElementsIBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 12/2020
1	Monoclonal AntibodiesIBA 12/2020

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 06/2022 - 09/2007
5	Craniotomy 01/2020 - 01/2010
4	Radiotherapy 04/2018 - 09/2007
2	Ventriculostomy 01/2022 - 09/2007
2	Anterior Temporal Lobectomy 12/2014 - 09/2010
2	Therapeutics 12/2014 - 01/2008
1	Immunotherapy 01/2021
1	Electrodes (Electrode) 01/2021